1. Doxey BW, Kuwada SK, Burt RW. Inherited
polyposis syndromes: molecular mechanisms, clinicopathology, and
genetic testing.
Clin Gastroenterol Hepatol. 2005;3:633-641.
[PubMed: 16206494]
2. Toccalino H, Guastavino E, De Pinni F, O’Donnell
JC, Williams M. Juvenile polyps of the rectum and colon.
Acta
Paediatr Scand. 1973;62: 337-340.
[PubMed: 4542332]
3. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis—a
precancerous condition.
Histopathology. 1988;13:619-630.
[PubMed: 2853131]
4. Giardiello FM, Hamilton SR, Kern SE, et al. Colorectal
neoplasia in juvenile polyposis or juvenile polyps.
Arch
Dis Child. 1991;66:971-975.
[PubMed: 1656892]
5. Sachatello CR, Griffen WO Jr. Hereditary polypoid diseases
of the gastrointestinal tract: a working classification.
Am
J Surg. 1975;129:198-203.
[PubMed: 1091175]
6. Zbuk KM, Eng C. Hamartomatous polyposis syndromes.
Nat
Clin Pract Gastroenterol Hepatol. 2007;4:492-502.
[PubMed: 17768394]
7. Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome
of juvenile polyposis and hereditary haemorrhagic telangiectasia
associated with mutations in MADH4 (SMAD4).
Lancet. 2004;363:852-859.
[PubMed: 15031030]
8. Aretz S, Stienen D, Uhlhaas S, et al. High proportion of
large genomic deletions and a genotype-phenotype update in 80 unrelated
families with juvenile polyposis syndrome.
J Med Genet. 2007;44:702–709.
[PubMed: 17873119]
9. van Hattem WA, Brosens LA, de Leng WW, et al. Large genomic
deletions of Smad4, Bmpr1a and PTEN in juvenile polyposis Gut. 2008;57:
623-7.
10. Howe JR, Sayed MG, Ahmed AF, et al. The prevalence of MADH4
and BMPR1A mutations in juvenile polyposis and absence of BMPR2,
BMPR1B, and ACVR1 mutations.
J Med Genet. 2004;
41:484-491.
[PubMed: 15235019]
11. Sweet K, Willis J, Zhou XP, et al. Molecular classification
of patients with unexplained hamartomatous and hyperplastic polyposis.
JAMA. 2005;294:2465-2473.
[PubMed: 16287957]
12. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal
carcinoma in familial juvenile polyposis.
Ann Surg Oncol. 1998;5:751-755.
[PubMed: 9869523]
13. Brosens LA, van Hattem A, Hylind LM, et al. Risk of colorectal
cancer in juvenile polyposis.
Gut. 2007;56:965-967.
[PubMed: 17303595]
14. Lynch HT, Lynch JF, Lynch PM, Attard T. Hereditary colorectal
cancer syndrome: molecular genetics, genetic counseling, diagnosis
and management. Fam Cancer. 2007;Nov 13 [Epub
ahead of print].
15. Utsunomiya J, Gocho H, Miyanaga T, Hamaguchi E, Kashimure
A. Peutz-Jeghers syndrome: its natural course and management. Johns
Hopkins Med J. 1975;136(2):71-82.
16. Hearle N, Schumacher V, Menko FH, et al. STK11 status and
intussusception risk in Peutz-Jeghers syndrome. J Med Genet. 2006;43:e41.
17. McGarrity TJ, Amos C. Peutz–Jeghers syndrome: clinicopathology
and molecular alterations.
Cell Mol Life Sci. 2006;63:2135-2144.
[PubMed: 16952058]
18. Giardiello FM, Brensinger JD, Tersmette, AC, et al. Very
high risk of cancer in familial Peutz–Jeghers syndrome.
Gastroenterology. 2000;119:1447-1453.
[PubMed: 11113065]
19. Lim W, Olschwang S, Keller JJ, et al. Relative frequency
and morphology of cancers in STK11 mutation carriers.
Gastroenterology. 2004;126:
1788-1794.
[PubMed: 15188174]
20. Giardiello FM, Trimbath JD. Peutz–Jeghers syndrome
and management recommendations.
Clin Gastroenterol Hepatol. 2006;4:408-415.
[PubMed: 16616343]
21. Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome.
Semin
Oncol. 2007;34:428-434.
[PubMed: 17920899]
22. Bosserhoff AK, Grussendorf-Conen EI, Rübben A,
et al. Multiple colon carcinomas in a patient with Cowden syndrome.
Int
J Mol Med. 2006; 18:643-647.
[PubMed: 16964417]
23. Genetic/Familial High-Risk Assessment: Breast and
Ovarian Guideline (V.1.2007) © 2006 National Comprehensive
Cancer Network, Inc. Available at:
www.nccn.org. Accessed
February 8, 2008.
24. Park J. Mesenteric plexiform neurofibroma in an 11-year-old
boy with von Recklinghausen disease. J Pediatr Surg. Jun
2007;42(6):E15–18.
25. Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen
N, Kindblom LG. NF1-associated gastrointestinal stromal tumors have
unique clinical, phenotypic, and genotypic characteristics.
Am
J Surg Pathol. Sep 2005; 29(9):1170-1176.
[PubMed: 16096406]
26. Ng C, Mam KY, Gupta TS, Ho YH. Inflammatory fibroid polyp
of the caecum in a patient with neurofibromatosis.
Ann Acad
Med Singapore. 2004;33:797-799.
[PubMed: 15608842]
27. Sathe PA, Kulkarni VM, Raunt AA, Deolekar SS, Joshi AS.
Ileal polyposis as manifestation of neurofibromatosis syndrome.
Indian
J Gastroenterol. 2006;25:159-160.
[PubMed: 16877836]
28. Digoy PG, Tibayan F, Young H, Edelstein P. Adenocarcinoma
of the rectum with associated colorectal adenomatous polyps in tuberous
sclerosis: a case report.
J Pediatr Surg. 2000;35:526-527.
[PubMed: 10726706]
29. Leung AKC, Ronson LM. Tuberous Sclerosis Complex: a review.
J
Pediatr Health Care. 2007; 21:108-114.
[PubMed: 17321910]
30. Schwartz RA. Basal-cell-nevus syndrome and gastrointestinal
polyposis. N Engl J Med. 1978;299 (1):49.
31. Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous
polyposis syndromes: a clinical and molecular review. Am
J Gastroenterol. 2005;100(2):476-490.
32. Leboulleux S, Travagli JP, Caillou B, et al. Medullary thyroid
carcinoma as part of a multiple endocrine neoplasia type 2B syndrome:
influence of the stage on the clinical course. Cancer. 2002;94(1):44-50.
33. Cohen MS, Phay JE, Albinson C, et al. Gastrointestinal manifestations
of multiple endocrine neoplasia type 2.
Ann Surg. 2002;235:648-654.
[PubMed: 11981210]
34. Szinnai G, Sarnacki S, Polak M. Hereditary medullary thyroid
carcinoma: how molecular genetics made multiple endocrine neoplasia
type 2 a paediatric disease.
Endocr Dev. 2007;10:173-187.
[PubMed: 17684396]
35. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis.
Am
J Gastroenterol. 2006;101:385-398.
[PubMed: 16454848]
36. Solomon C, Burt RW. APC-Associated Polyposis Conditions,
GeneReviews. Available at:
www.genetests.org. Accessed
February 8, 2008.
37. Rustin RB, Jagelman DG, McGannon E, Fazio VW, Lavery IC,
Weakley FL Spontaneous mutation in familial adenomatous polyposis.
Dis
Colon Rectum. 1990;33:52–55.
[PubMed: 2153067]
38. Burt RW. Gastric fundic gland polyps.
Gastroenterology. 2003;125:1462–1469.
[PubMed: 14598262]
39. Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of
APC mutations in children with hepatoblastoma from familial adenomatous polyposis
kindreds.
J Pediatr. 2005;147:263-266.
[PubMed: 16126064]
40. Wijn MA, Keller JJ, Giardiello FM, Brand HS. Oral and maxillofacial
manifestations of familial adenomatous polyposis.
Oral Diseases. 2007;
13:360-365.
[PubMed: 17577321]
41. Attard TM, Giglio P, Koppula S, Snyder C, Lynch HT. Brain
tumors in individuals with familial adenomatous polyposis: a cancer
registry experience and pooled case report analysis.
Cancer. 2007;109:761-766.
[PubMed: 17238184]
42. Clinical Practice Guidelines in Oncology—Colorectal
Cancer Screening (V.1.2007) © 2007. National Comprehensive
Cancer Network. Inc. Available at:
www.nccn.org. Accessed
February 8, 2008.
43. Wang L, Baudhuin LM, Boardman LA, et al. MYH mutations in
patients with attenuated and classic polyposis and with young-onset
colorectal cancer without polyps.
Gastroenterology. 2004;127:9-16.
[PubMed: 15236166]
44. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive
colorectal adenomatous polyposis due to inherited mutations of MYH.
Lancet. 2003;362:39-41.
[PubMed: 12853198]
45. Huang SC, Lavine JE, Boland PS, et al. Germline characterization
of early-aged onset of hereditary non-polyposis colorectal cancer.
J
Pediatr. 2001;138:629-635.
[PubMed: 11343035]
46. Durno C, Aronson M, Bapat B, et al. Family history and molecular
features of children, adolescents, and young adults with colorectal carcinoma.
Gut. 2005;54:1146-1150.
[PubMed: 15845562]
47. Bodas A, Perez-Segura P, Maluenda C, Caldés T,
Olivera E, Diaz-Rubio E. Lynch syndrome in a 15-year-old boy. Eur
J Pediatr. 2008 [Jan 4 E-pub].
48. Gallinger S, Aronson M, Shayan K, et al. Gastrointestinal
cancers and neurofibromatosis type 1 features in children with a
germline homozygous MLH1 mutation.
Gastroenterology. 2004;126:576-585.
[PubMed: 14762794]
49. Muller A, Schackert HK, Lange B, et al. A novel MSH2 germline
mutation in homozygous state in two brothers with colorectal cancers
diagnosed at the age of 11 and 12 years. Am J Med Genet. 2006;140A:195-199.
50. Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic
heterogeneity in the Lynch syndrome: diagnostic, surveillance and
management implications.
Europ J Hum Genet. 2006;14:390-402.
[PubMed: 16479259]
51. Nagata J, Kijima H, Hasumi K, Suzuki T, Shirai T, Mine T.
Adenocarcinoma and multiple adenomas of the large intestine, associated
with Cronkhite-Canada syndrome. Dig Liver Dis. 2003;35(6):434-438.
52. Chadalavada R, Brown DK, Walker AN, Sedghi S. Cronkhite-Canada
syndrome: sustained remission after corticosteroid treatment. Am
J Gastroenterol. 2003;98(6):1444-1446.
53. Hizawa K, Nakamori M, Yao T, Matsumoto T, Iida M. A case
of Cronkhite-Canada syndrome with colorectal adenomas: effect of
the nonsteroidal anti-inflammatory drug sulindac. Am J Gastroenterol. 2007;102(8):1831-1832.
54. Kokkonen J, Holm K, Karttunen TJ, Maki M. Enhanced local
immune response in children with prolonged gastrointestinal symptoms. Acta
Paediatr. 2004;93(12):1601-1607.
55. Kokkonen J, Ruuska T, Karttunen TJ, Maki M. Lymphonodular
hyperplasia of the terminal ileum associated with colitis shows
an increase gamma delta + t-cell density in children. Am
J Gastroenterol. 2002;97(3):667-672.
56. Inan N, Arslan AS, Akansel G, Anik Y, Gurbuz Y, Tugay M.
Colitis cystica profunda: MRI appearance. Abdom Imaging. 2007;32(2):239-242.
57. Thielen BK, Barker DF, Nelson RD, Zhou J, Kren SM, Segal
Y. Deletion mapping in Alport syndrome and Alport syndrome-diffuse
leiomyomatosis reveals potential mechanisms of visceral smooth muscle
overgrowth.
Hum Mutat. 2003;22(5):419.
[PubMed: 14517961]
58. Carney JA. Gastric stromal sarcoma, pulmonary chondroma,
and extra-adrenal paraganglioma (Carney Triad): natural history,
adrenocortical component, and possible familial occurrence. Mayo
Clin Proc. 1999;74(6):543-552.
60. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic
criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber
syndrome). Am J Med Genet. 2000;91(1):66-67.
61. HHT Foundation International I. Available at:
www.hht.org.
Accessed January 29, 2008.
62. Wilson CL, Song LM, Chua H, et al. Bleeding from cavernous
angiomatosis of the rectum in Klippel-Trenaunay syndrome: report
of three cases and literature review. Am J Gastroenterol. 2001;96(9):2783-2788.
63. Sauseng W, Benesch M, Lackner H, et al. Clinical, radiological,
and pathological findings in four children with gastrointestinal
stromal tumors of the stomach. Pediatr Hematol Oncol. 2007;24(3):209-219.
64. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal
tumors of the stomach in children and young adults: a clinicopathologic,
immunohistochemical, and molecular genetic study of 44 cases with
long-term follow-up and review of the literature.
Am J Surg
Pathol. 2005;29(10):1373–1381.
[PubMed: 16160481]
65. Crocetti E, Paci E. Malignant carcinoids in the USA, SEER
1992–1999. An epidemiological study with 6830 cases. Eur
J Cancer Prev. 2003;12(3): 191-194.
66. Nikou GC, Lygidakis NJ, Toubanakis C, et al. Current diagnosis
and treatment of gastrointestinal carcinoids in a series of 101
patients: the significance of serum chromogranin-A, somatostatin receptor
scintigraphy and somatostatin analogues. Hepatogastroenterology. 2005;52(63):731-741.
67. Berna MJ, Hoffmann KM, Serrano J, Gibril F, Jensen RT. Serum
gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting
serum gastrin in 309 patients from the National Institutes of Health
and comparison with 2229 cases from the literature.
Medicine
(Baltimore). 2006; 85(6):295-330.
[PubMed: 17108778]
68. Berna MJ, Hoffmann KM, Long SH, Serrano J, Gibril F, Jensen
RT. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective
study of gastrin provocative testing in 293 patients from the National Institutes
of Health and comparison with 537 cases from the literature. Evaluation
of diagnostic criteria, proposal of new criteria, and correlations
with clinical and tumoral features. Medicine (Baltimore). 2006;85(6):331-364.
69. Norton JA, Jensen RT. Resolved and unresolved controversies
in the surgical management of patients with Zollinger-Ellison syndrome. Ann
Surg. 2004;240(5):757-773.
70. Norton JA, Fraker DL, Alexander HR, et al. Surgery increases
survival in patients with gastrinoma. Ann Surg. 2006;244(3):410-419.